Mineralys Therapeutics, Inc.
MLYS
$14.25
$0.755.56%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
3/14/2025
-
MarketBeat
3/13/2025
-
MarketBeat
3/12/2025
-
MarketBeat
3/12/2025
-
Benzinga
3/12/2025
-
SeekingAlpha.com: All News
3/12/2025
-
Seeking Alpha - Healthcare
3/12/2025
-
MarketBeat
3/12/2025
-
GuruFocus
3/12/2025
-
GuruFocus
3/12/2025
-
TipRanks Financial Blog
3/12/2025
-
The Fly
3/12/2025
-
Globe Newswire
3/11/2025
-
Ticker Report
3/11/2025
-
MarketBeat
3/11/2025
-
MarketBeat
3/10/2025
-
GuruFocus
3/10/2025
-
Seeking Alpha - Healthcare
3/10/2025
-
TipRanks Financial Blog
3/10/2025
-
The Fly
3/10/2025
-
Globe Newswire
3/10/2025
-
Stock Options Channel
3/10/2025
-
Benzinga
3/10/2025
-
BizJournals.com - Nat'l Business News
3/10/2025
-
GuruFocus
3/10/2025
-
The Fly
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Wednesday, February 12, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of Mar 17 and 21 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
888 378 6240
Address
150 N. Radnor Chester Rd.
Radnor, PA 19087
Radnor, PA 19087
Country
Year Founded
Business Description
Sector
Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines to target diseases driven by dysregulated aldosterone in the United States. The company’s...
more
